Hosmani, J.; Mushtaq, S.; Abullais, S.S.; Almubarak, H.M.; Assiri, K.; Testarelli, L.; Mazzoni, A.; Patil, S.
Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review. Medicina 2021, 57, 438.
https://doi.org/10.3390/medicina57050438
AMA Style
Hosmani J, Mushtaq S, Abullais SS, Almubarak HM, Assiri K, Testarelli L, Mazzoni A, Patil S.
Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review. Medicina. 2021; 57(5):438.
https://doi.org/10.3390/medicina57050438
Chicago/Turabian Style
Hosmani, Jagadish, Shazia Mushtaq, Shahabe Saquib Abullais, Hussain Mohammed Almubarak, Khalil Assiri, Luca Testarelli, Alessandro Mazzoni, and Shankargouda Patil.
2021. "Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review" Medicina 57, no. 5: 438.
https://doi.org/10.3390/medicina57050438
APA Style
Hosmani, J., Mushtaq, S., Abullais, S. S., Almubarak, H. M., Assiri, K., Testarelli, L., Mazzoni, A., & Patil, S.
(2021). Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review. Medicina, 57(5), 438.
https://doi.org/10.3390/medicina57050438
